Poland· PL-100444490
Comirnaty
A covid-19, rna-based vaccine product containing szczepionka mrna przeciw covid-19 (ze zmodyfikowanymi nukleozydami), registered in Poland by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Covid-19, rna-based vaccine is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Covid-19, rna-based vaccine · ATC J07BN01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka mRNA przeciw COVID-19 (ze zmodyfikowanymi nukleozydami)
- Manufacturer
- BioNTech Manufacturing GmbH
- Country
- Poland (PL)
- ATC code
- J07BN01
- ATC class
- Covid-19, RNA-based vaccine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin04260703260002
- gtin05909991444471
- gtin05909991444488
- gtin05909991445072
- gtin05909991445089
- gtin05909991445492
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BN01
Covid-19, rna-based vaccine, as other registers publish it.
- IrelandBIMERVAX emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted)Hipra Human Health S.L.
- IrelandComirnatyBioNTech Manufacturing GmbH
- IrelandComirnatyBioNTech Manufacturing GmbH
- FinlandComirnatyBioNTech Manufacturing GmbH
- FinlandComirnatyBioNTech Manufacturing GmbH
- FinlandComirnatyBioNTech Manufacturing GmbH
- IrelandComirnatyBioNTech Manufacturing GmbH
- FinlandComirnatyBioNTech Manufacturing GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2bd4d0a-b122-4498-a9f9-ff34971847ac GET /v1/drugs/e2bd4d0a-b122-4498-a9f9-ff34971847ac?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania dyspersji do wstrzykiwań",
"source": "urpl",
"strength": "30 mcg(0,3 ml)/dawkę",
"packaging": "04260703260002 ¦ Rp ¦ Skasowane ¦ EU/1/20/1528/001 ¦ 138602\n195 fiol. 1,5 ml (5 dawek/fiol.)\n05909991444471 ¦ Rp ¦ 138681\n15 fiol. (75 dawek)\n05909991444488 ¦ Rp ¦ 138682\n195 fiol. (975 dawek, 5 dawek/fiol.)\n05909991445072 ¦ Rp ¦ 138741\n15 fiol. (90 dawek)\n05909991445089 ¦ Rp ¦ 138742\n195 fiol. (1170 dawek, 6 dawek/fiol.)\n05909991445492 ¦ Rp ¦ 138855\n5 fiol. 30 dawek (6 dawek/fiol.)",
"substance": null,
"common_name": "Szczepionka mRNA przeciw COVID-19 (ze zmodyfikowanymi nukleozydami)",
"pl_product_id": "100444490",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about covid-19, rna-based vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.